News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,946 Results
Type
Article (39656)
Company Profile (247)
Press Release (658043)
Multimedia
Podcasts (48)
Webinars (12)
Section
Business (204145)
Career Advice (2007)
Deals (35414)
Drug Delivery (95)
Drug Development (81036)
Employer Resources (172)
FDA (16175)
Job Trends (14853)
News (345148)
Policy (32530)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49419)
ALS (87)
Alzheimer's disease (1372)
Antibody-drug conjugate (ADC) (122)
Approvals (16177)
Artificial intelligence (246)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (66)
Brain cancer (26)
Breast cancer (271)
Cancer (2165)
Cardiovascular disease (170)
Career advice (1675)
Career pathing (30)
CAR-T (145)
Cell therapy (406)
Cervical cancer (19)
Clinical research (65910)
Collaboration (814)
Compensation (519)
Complete response letters (19)
COVID-19 (2584)
CRISPR (37)
C-suite (231)
Cystic fibrosis (100)
Data (2094)
Decentralized trials (2)
Denatured (18)
Depression (41)
Diabetes (263)
Diagnostics (6356)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (92)
Earnings (86441)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112097)
Executive appointments (706)
FDA (17387)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (741)
Gene editing (100)
Generative AI (19)
Gene therapy (287)
GLP-1 (703)
Government (4411)
Grass and pollen (4)
Guidances (52)
Healthcare (18812)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (28)
Infectious disease (2726)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (92)
Interviews (311)
IPO (16499)
IRA (40)
Job creations (3629)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (462)
Leadership (16)
Legal (7909)
Liver cancer (73)
Lung cancer (311)
Lymphoma (147)
Machine learning (6)
Management (58)
Manufacturing (295)
MASH (65)
Medical device (13360)
Medtech (13365)
Mergers & acquisitions (19443)
Metabolic disorders (669)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (27)
Neuroscience (1887)
NextGen: Class of 2025 (6512)
Non-profit (4477)
Northern California (2598)
Now hiring (39)
Obesity (358)
Opinion (204)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (227)
Patient recruitment (105)
Peanut (46)
People (57247)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20526)
Phase II (29023)
Phase III (21629)
Pipeline (1139)
Policy (135)
Postmarket research (2563)
Preclinical (8691)
Press Release (64)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (373)
Real estate (5906)
Recruiting (65)
Regulatory (22231)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (128)
Series B (83)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2230)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3575)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (33)
The Weekly (28)
United States (22452)
Vaccines (676)
Venture capitalists (41)
Weight loss (231)
Women's health (35)
Worklife (15)
Date
Today (40)
Last 7 days (640)
Last 30 days (2360)
Last 365 days (32706)
2025 (9842)
2024 (35218)
2023 (40076)
2022 (51175)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (230)
Arkansas (13)
Asia (37802)
Australia (6179)
California (5928)
Canada (1969)
China (503)
Colorado (260)
Connecticut (265)
Delaware (139)
Europe (81112)
Florida (878)
Georgia (202)
Idaho (57)
Illinois (519)
India (25)
Indiana (305)
Iowa (11)
Japan (157)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (870)
Massachusetts (4418)
Michigan (216)
Minnesota (384)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1679)
New Mexico (28)
New York (1687)
North Carolina (950)
North Dakota (7)
Northern California (2598)
Ohio (199)
Oklahoma (14)
Oregon (34)
Pennsylvania (1335)
Puerto Rico (11)
Rhode Island (32)
South America (1096)
South Carolina (22)
South Dakota (1)
Southern California (2230)
Tennessee (101)
Texas (879)
Utah (177)
Virginia (140)
Washington D.C. (61)
Washington State (543)
West Virginia (3)
Wisconsin (52)
697,946 Results for "imaginab inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
January 23, 2025
·
3 min read
Biotech Beach
ImaginAb Advances Two Solid Tumor Radiopharmaceutical Therapy (RPT) Candidates Towards Clinical Development
ImaginAb, Inc. announced lead selection and progression to IND-enabling studies of IAB56, a minibody designed to target the αvβ6 integrin for use as Lu-177 radiopharmaceutical therapy in solid tumors.
May 18, 2023
·
2 min read
Drug Development
New analysis of Phase II data at AACR assesses ImaginAb’s investigational CD8 ImmunoPET technology’s ability to predict response in immunotherapy
ImaginAb Inc., a global biotechnology company developing 89Zr crefmirlimab berdoxam imaging agent and radiopharmaceutical therapies announces a poster presentation at AACR 2023 of an independent analysis undertaken by AstraZeneca, on data from ImaginAb’s IAB-CD8-201 ‘iCorrelate’ Phase II study.
April 14, 2023
·
2 min read
Biotech Beach
ImaginAb Executes New License and Supply Agreement for CD8 ImmunoPET Technology with Leucid Bio
ImaginAb Inc. is pleased to announce the execution of a new non-exclusive License and Supply Agreement with Leucid Bio, a biotech company pursuing a differentiated approach to develop next generation Chimeric Antigen Receptor T-cell therapies using the Company’s proprietary Lateral CAR Platform.
April 12, 2023
·
3 min read
Business
Parthenon Therapeutics and ImaginAb Announce License and Supply Agreement to Advance New Class of Anti-Cancer Therapies’ Clinical Development Program
Parthenon Therapeutics and ImaginAb Inc. today announced that the companies have entered into a multi-year, non-exclusive license and supply agreement.
November 10, 2022
·
6 min read
Business
Imaging Endpoints (IE) and ImaginAb Inc Expand Partnership - IE to Supply Clinical Doses of CD8 Imaging Agent to BioPharma Companies
Imaging Endpoints (IE) and ImaginAb announced today that after collaborating for nearly a decade they have entered into a license agreement for IE to directly offer clinical doses of ImaginAb’s CD8 investigational ImmunoPET (zirconium Zr 89 crefmirlimab berdoxam) imaging agent for clinical trials as part of Imaging Endpoints’ industry-leading imaging CRO services.
June 3, 2022
·
3 min read
Business
BriaCell and ImaginAb Announce Collaboration to Evaluate Immunotherapy Imaging Technology in Advanced Breast Cancer
BriaCell Therapeutics Corp. jointly announces a multi-year, non-exclusive license agreement with ImaginAb Inc
August 19, 2021
·
5 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Press Releases
Penumbra, Inc. Reports First Quarter 2025 Financial Results
April 23, 2025
·
15 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025
April 21, 2025
·
4 min read
1 of 69,795
Next
